Phosphorylation and Functional Inactivation of TSC2 by Erk Implications for Tuberous Sclerosisand Cancer Pathogenesis

@article{Ma2005PhosphorylationAF,
  title={Phosphorylation and Functional Inactivation of TSC2 by Erk Implications for Tuberous Sclerosisand Cancer Pathogenesis},
  author={Li Ma and Zhenbang Chen and Hediye Erdjument-Bromage and Paul Tempst and Pier Paolo Pandolfi},
  journal={Cell},
  year={2005},
  volume={121},
  pages={179-193}
}

Figures from this paper

TSC2 Deficiency Increases PTEN via HIF1α*

The results reveal a unique function of HIF1α in up-regulation of PTEN and provide a new mechanism of reduced Akt phosphorylation in Tsc2 null cells, suggesting that PTEN may safeguard against developing malignant tumors in patients with TSC deficiency.

A genetic model to dissect the role of Tsc-mTORC1 in neuronal cultures.

A genetic model of mTOR complex 1 (m TORC1) activation in culture is established by using lentiviral vector-mediated TSC2 knockdown, which offers a reliable tool for analyzing the TSC-mTORC1 signaling in neurons.

Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways.

In the absence of either TSC1 or TSC2, high levels of Rheb-GTP lead to constitutive activation of mTOR-raptor signaling, thereby leading to enhanced and deregulated protein synthesis and cell growth.

Mesenchymal Tumorigenesis Driven by TSC2 Haploinsufficiency Requires HMGA2 and Is Independent of mTOR Pathway Activation.

Findings demonstrate that tissue-specific genetic mechanisms are employed to promote tumor pathogenesis in TSC and identify a novel, critical pathway for potential therapeutic targeting.

Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease

How the TSC signaling pathways are affected by mutations in TSC1 or TSC2 are discussed, focusing on how these mutations may lead to the renal and pulmonary manifestations of TSC.

Identification of S664 TSC2 phosphorylation as a marker for extracellular signal-regulated kinase mediated mTOR activation in tuberous sclerosis and human cancer.

It is found that Erk-mediated TSC2 phosphorylation occurred at a high incidence and positively correlated with mitogen-activated protein kinase (MAPK) and mammalian target of rapamycin (mTOR) activation in TSC-associated brain lesions as well as in various cancers.

Positive and negative regulation of TSC2 activity and its effects on downstream effectors of the mTOR pathway

Very recent information contributing to the authors' knowledge of TSC2 regulation by four cellular signaling pathways are summarized: PI3K/Akt, Ras/MAPK, LKB1/AMPK, and REDD1.

Anti-EGFR Antibody Efficiently and Specifically Inhibits Human TSC2−/− Smooth Muscle Cell Proliferation. Possible Treatment Options for TSC and LAM

The results show that an EGF independent pathway is more important than that involving IGF-I for growth and survival of TSC−/− ASM cells, and such EGF-dependency is the result of the lack of tuberin.
...

References

SHOWING 1-10 OF 65 REFERENCES

TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling

It is shown that TSC1–TSC2 inhibits the p70 ribosomal protein S6 kinase 1 and activates the eukaryotic initiation factor 4E binding protein 1 (4E-BP1, an inhibitor of translational initiation) and these functions are mediated by inhibition of the mammalian target of rapamycin (mTOR).

Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR.

Tuberous sclerosis (TSC) is a familial tumor syndrome due to mutations in TSC1 or TSC2, in which progression to malignancy is rare. Primary Tsc2(-/-) murine embryo fibroblast cultures display early

Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome.

It is shown that LKB1, the gene mutated in PJS, acts as a tumor suppressor by activating TSC2, the Gene mutated in TSC, which suggests that PJS and other benign tumor syndromes could be caused by dysregulation of the TSC 2/mTOR pathway.

TSC2: filling the GAP in the mTOR signaling pathway.

Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling.

The data demonstrate that Rheb acts downstream of TSC1/TSC2 and upstream of mTOR to regulate cell growth and plays an essential role in regulation of S6K and 4EBP1 in response to nutrients and cellular energy status.

Akt regulates growth by directly phosphorylating Tsc2

Drosophila melanogaster Tsc2 seems to be the critical target of Akt in mediating growth signals for the insulin signalling pathway, and Stimulating Akt/PKB signalling in vivo markedly increases cell growth/size, disrupts the Tsc1–Tsc2 complex and disturbs the distinct subcellular localization of T Sc2.
...